Related references
Note: Only part of the references are listed.Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia
Bogdan Dumitriu et al.
BLOOD (2015)
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria
Antonio M. Risitano et al.
BLOOD (2014)
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome
Austin G. Kulasekararaj et al.
BLOOD (2014)
Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study
Alexander Kulagin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria
Wenyi Shen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT
Peter M. Krawitz et al.
BLOOD (2013)
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
Peter Hillmen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
The rate of spontaneous mutations in human myeloid cells
David J. Araten et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2013)
The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment
Antonio M. Risitano et al.
BLOOD (2012)
Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria
Regis Peffault de Latour et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Paroxysmal nocturnal hemoglobinuria and concurrent JAK2V617F mutation
C. Sugimori et al.
BLOOD CANCER JOURNAL (2012)
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
Richard J. Kelly et al.
BLOOD (2011)
Management of Paroxysmal Nocturnal Haemoglobinuria: a personal view
Lucio Luzzatto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia
Jeffrey J. Pu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena
Alexander Roeth et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
Peter Hillmen et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Aplastic Anemia: Pathophysiology and Treatment
Neal S. Young et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria
Adnan Alahmad et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria
Anita Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Paroxysmal nocturnal hemoglobinuria turning Coombs-positive
Alexander Roeth et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria
Ashkan Emadi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
Antonio M. Risitano et al.
BLOOD (2009)
Guidelines for the diagnosis and management of aplastic anaemia
Judith C. W. Marsh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Paroxysmal nocturnal hemoglobinuria:: natural history of disease subcategories
Regis Peffault de Latour et al.
BLOOD (2008)
Die paroxysmale nächtliche Hämoglobinurie - ein erworbener genetischer Defekt der hämatopoietischen Stammzelle*
J. Schubert et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
Robert A. Brodsky et al.
BLOOD (2008)
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
Peter Hillmen et al.
BLOOD (2007)
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
Russell P. Rother et al.
NATURE BIOTECHNOLOGY (2007)
The pathophysiology of paroxysmal nocturnal hemoglobinuria
Charles J. Parker
EXPERIMENTAL HEMATOLOGY (2007)
Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH)
Norimitsu Inoue et al.
BLOOD (2006)
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
Peter Hillmen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria
Lucio Luzzatto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism
Ludo Luzzatto
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
C Parker et al.
BLOOD (2005)
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin - A novel mechanism of human disease
RP Rother et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays
VM Moyo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan
JI Nishimura et al.
MEDICINE (2004)
Autoantibodies frequently detected in patients with aplastic anemia
N Hirano et al.
BLOOD (2003)
Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH)
C Hall et al.
BLOOD (2003)
The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH):: a high incidence of multiple mutations and evidence of a mutational hot spot
Y Mortazavi et al.
BLOOD (2003)
Clinical manifestations of paroxysmal nocturnal hemoglobinuria: Present state and future problems
WF Rosse et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria
U Hegenbart et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome
JP Maciejewski et al.
BLOOD (2001)
Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones
JP Maciejewski et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria
K Suenaga et al.
EXPERIMENTAL HEMATOLOGY (2001)
Acute myelogenous leukemia with PIG-A gene mutation evolved from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome
H Tanaka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)
Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin
H Ninomiya et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
